| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Solid Biosciences Inc. (SLDB) has 15 insiders with recent SEC Form 4 filings, including 3 buys and 7 sells. SLDB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.91M | $64.80M | - | |
| CEO | 235.4K | $1.71M | - | |
| Dir | 131.3K | $954.3K | - | |
| COO | 105.1K | $763.9K | - | |
| CFO | 99.4K | $722.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 3, 2024 | Hanrahan Jessie | Chief Regulatory Officer | Sale+OE | 4,610 | $5.60 | $25,822.45 | -24.5% | -1.2% | +0.2% | |
| Dec 3, 2024 | Cumbo Alexander | President And CEO | Sale+OE | 11,114 | $5.60 | $62,236.18 | -22.4% | -1.2% | +0.2% | |
| Dec 3, 2024 | Howton David T | Chief Operating Officer | Sale+OE | 5,072 | $5.60 | $28,396.10 | -24.5% | -1.2% | +0.2% | |
| Dec 3, 2024 | Herzich Paul | Chief Technology Officer | Sale+OE | 2,777 | $5.60 | $15,550.64 | -18.6% | -1.2% | +0.2% | |
| Oct 21, 2024 | Brooks Gabriel | Chief Medical Officer | Sale+OE | 2,923 | $6.50 | $18,999.50 | -21.0% | -44.0% | +3.3% | |
| Jun 7, 2024 | Kahn Clare | Director | Buy | 1,100 | $7.67 | $8,441.62 | New | +5.6% | -43.7% | |
| May 2, 2024 | Ganot Ilan60 | Director | Sale+OE | 462 | $10.33 | $4,772.46 | -4.6% | -12.8% | -57.9% | |
| Jan 29, 2024 | Ganot Ilan60 | Director | Sale+OE | 139 | $7.99 | $1,110.61 | -1.6% | +10.4% | -58.8% | |
| Jan 11, 2024 | Perceptive Advisors LLC51 | Director, 10% Owner | Buy | 3,410,713 | $5.53 | $18,861,242.89 | +99.6% | +40.6% | -52.2% | |
| Jan 11, 2024 | Ra Capital Management, L.P.52 | Director, 10% Owner | Buy | 904,160 | $5.53 | $5,000,004.80 | +27.5% | +40.6% | -52.2% |